ERNESTINA ARCHER: Open Payments
NPI 1376064915 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,226 in 71 payments from 12 companies in 2025. Trend: 2023 $540 · 2024 $1,780 · 2025 $1,226
Food & beverage: $1,226
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 37 | $531 |
| ABBVIE INC. | 14 | $184 |
| Otsuka America Pharmaceutical, Inc. | 6 | $184 |
| Abbott Laboratories | 1 | $104 |
| Teva Pharmaceuticals USA, Inc. | 4 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Lundbeck LLC | 2 | $37 |
| Lilly USA, LLC | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: CAPLYTA, REXULTI, VRAYLAR, FREESTYLE LIBRE 3, AUSTEDO XR, INGREZZA, MOUNJARO, FANAPT.
Industry payments across NJ — which companies pay providers there.
